Streptococcus pneumoniae type 6b capsular polysaccharide antigen
- Generic Name
- Streptococcus pneumoniae type 6b capsular polysaccharide antigen
- Brand Names
- Pneumovax 23, Prevnar 13, Vaxneuvance, Prevenar 13
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 57F7254B6Q
Overview
Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Background
Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Indication
No indication information available.
Associated Conditions
- Pneumococcal Infection
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.